Cargando…
Ion Channels as Therapeutic Targets in High Grade Gliomas
SIMPLE SUMMARY: Glioblastoma multiforme is an aggressive grade IV lethal brain tumour with a median survival of 14 months. Despite surgery to remove the tumour, and subsequent concurrent chemotherapy and radiotherapy, there is little in terms of effective treatment options. Because of this, explorin...
Autores principales: | Griffin, Michaela, Khan, Raheela, Basu, Surajit, Smith, Stuart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589494/ https://www.ncbi.nlm.nih.gov/pubmed/33096667 http://dx.doi.org/10.3390/cancers12103068 |
Ejemplares similares
-
HGG-28. CLIC1 and CLIC4 ion channel deficiency confers increased sensitivity to tumour treating fields and improved survival in paediatric glioblastoma
por: Griffin, Michaela, et al.
Publicado: (2022) -
Eag and HERG potassium channels as novel therapeutic targets in cancer
por: Asher, Viren, et al.
Publicado: (2010) -
Ligand-Gated Ion Channels: Prognostic and Therapeutic Implications for Gliomas
por: Hey, Grace, et al.
Publicado: (2023) -
Tumour treating fields in a combinational therapeutic approach
por: Branter, Joshua, et al.
Publicado: (2018) -
Potassium Ion Channels in Glioma: From Basic Knowledge into Therapeutic Applications
por: Younes, Samar, et al.
Publicado: (2023)